Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Clinical trial NCT00590954 · COMPLETED
Trial details
- NCT number
- NCT00590954
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2019-11-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.